{"filing":{"accession_number":"0001213900-26-071745","cik":"0001873875","ticker":"IXHL","company_name":"Incannex Healthcare Inc.","form":"8-K","filing_date":"2026-06-25","report_date":null,"primary_document":"ea0295769-8k_incannex.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026071745/ea0295769-8k_incannex.htm"},"events":[{"id":13708,"run_id":12176,"accession_number":"0001213900-26-071745","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"The filing discloses a U.S. patent grant for IHL-42X in obstructive sleep apnoea with an expiry date of July 9, 2040, plus potential patent term extension eligibility. This is a material intellectual property milestone for a clinical-stage biopharmaceutical company's lead program, strengthening its competitive position and long-term exclusivity. While not fitting a specific named event type, this is clearly an operational/strategic business event—a regulatory/IP milestone—that would affect a reasonable investor's assessment of the company's asset value and development trajectory.","company_name":"Incannex Healthcare Inc.","ticker":"IXHL","filing_date":"2026-06-25","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":10927,"accession_number":"0001213900-26-071745","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses a U.S. patent grant for IHL-42X in obstructive sleep apnoea with an expiry date of July 9, 2040, plus potential patent term extension eligibility. This is a material intellectual property milestone for a clinical-stage biopharmaceutical company's lead program, strengthening its competitive position and long-term exclusivity. While not fitting a specific named event type, this is clearly an operational/strategic business event—a regulatory/IP milestone—that would affect a reasonable investor's assessment of the company's asset value and development trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T11:31:40.529376+00:00","company_name":"Incannex Healthcare Inc.","ticker":"IXHL","filing_date":"2026-06-25"}]}